Paper35865481
PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.
Jiang D and 12 others. Front Oncol, 2022. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma. Papers, record 35865481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35865481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25214542 | The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Ann Oncol | 2015 | https://conductscience.org/library/papers/25214542 | PubMed |
| 2 | 30296523 | PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma. | Hum Pathol | 2019 | https://conductscience.org/library/papers/30296523 | PubMed |
| 3 | 17044039 | Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer. | Prostate | 2007 | https://conductscience.org/library/papers/17044039 | PubMed |
| 4 | 34419685 | Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC. | J Thorac Oncol | 2021 | https://conductscience.org/library/papers/34419685 | PubMed |
| 5 | 24614649 | Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis. | Eur J Cancer Prev | 2014 | https://conductscience.org/library/papers/24614649 | PubMed |
| 6 | 32449246 | Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32449246 | PubMed |
| 7 | 32937743 | Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32937743 | PubMed |
| 8 | 33816285 | POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy. | Front Oncol | 2021 | https://conductscience.org/library/papers/33816285 | PubMed |
| 9 | 32736034 | Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies. | Drug Resist Updat | 2020 | https://conductscience.org/library/papers/32736034 | PubMed |
| 10 | 32060377 | Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma. | Mod Pathol | 2020 | https://conductscience.org/library/papers/32060377 | PubMed |
| 11 | 33247565 | PMS2: a potential prognostic protein marker in oral squamous cell carcinoma. | Med Oral Patol Oral Cir Bucal | 2021 | https://conductscience.org/library/papers/33247565 | PubMed |
| 12 | 17397816 | DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. | Clin Chim Acta | 2007 | https://conductscience.org/library/papers/17397816 | PubMed |
| 13 | 34218257 | PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma. | Mod Pathol | 2021 | https://conductscience.org/library/papers/34218257 | PubMed |
| 14 | 26559582 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26559582 | PubMed |
| 15 | 34272092 | PD-L1 expression in tumor cells is associated with a favorable prognosis in patients with high-risk endometrial cancer. | Gynecol Oncol | 2021 | https://conductscience.org/library/papers/34272092 | PubMed |
| 16 | 28522752 | Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis. | Cancer Res | 2017 | https://conductscience.org/library/papers/28522752 | PubMed |
| 17 | 16231369 | Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. | J Surg Oncol | 2005 | https://conductscience.org/library/papers/16231369 | PubMed |
| 18 | 26028255 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26028255 | PubMed |
| 19 | 34009410 | Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. | Cancer Immunol Immunother | 2022 | https://conductscience.org/library/papers/34009410 | PubMed |
| 20 | 31623180 | Relationship between Microsatellite Instability, Immune Cells Infiltration, and Expression of Immune Checkpoint Molecules in Ovarian Carcinoma: Immunotherapeutic Strategies for the Future. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31623180 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42038015 | High PMS2 Expression-Based Nomogram for Risk Stratification in Resected Hepatocellular Carcinoma: Application to Recurrence and Neoadjuvant Therapy Selection. | J Cancer | 2026 | https://conductscience.org/library/papers/42038015 | PubMed |
| 40587482 | The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance. | PLoS One | 2025 | https://conductscience.org/library/papers/40587482 | PubMed |
| 40416179 | Mismatch Repair Deficiency in Esophageal Squamous Cell Carcinoma: An Underrecognized Biomarker for Immunotherapy Response. | Cureus | 2025 | https://conductscience.org/library/papers/40416179 | PubMed |
| 38975889 | Characteristics of auto-quantified tumor-infiltrating lymphocytes and the prognostic value in adenocarcinoma of the esophagogastric junction, gastric adenocarcinoma, and esophageal squamous cell carcinoma. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38975889 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CPS1 | 1373 | PubTator's text mining | https://conductscience.org/library/genes/1373 | NCBI Gene |
| MLH1 | 4292 | PubTator's text mining | https://conductscience.org/library/genes/4292 | NCBI Gene |
| MSH2 | 4436 | PubTator's text mining | https://conductscience.org/library/genes/4436 | NCBI Gene |
| MSH6 | 2956 | PubTator's text mining | https://conductscience.org/library/genes/2956 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| PMS2 | 5395 | PubTator's text mining | https://conductscience.org/library/genes/5395 | NCBI Gene |
| PRB1 | 5542 | PubTator's text mining | https://conductscience.org/library/genes/5542 | NCBI Gene |
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35865481
GET https://conductscience.org/api/papers/v1/35865481/references?page=2